The California biotech firm said in a statement that it is hoping to find a buyer to address its ongoing financial struggles.
The arc of biotechnology is one of breakthroughs and struggles, writes Tim Hunt, CEO of the Alliance for Regenerative ...
The genetic testing company holds biological information on millions of people.
Me has filed for bankruptcy, and CEO Anne Wojcicki is resigning. It once helped usher in the era of consumer DNA test kits ...
Offering free solutions can generate goodwill and strengthen relationships with both existing and potential customers. When a ...
Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine ...
The stock of 23andMe dropped 59% Monday after filing for federal bankruptcy protection and the exit of its CEO, a dramatic ...
14h
Montgomery Advertiser on MSNBad genes: 23andMe announces it has filed for Chapter 11 bankruptcyMe has filed for the Chapter 11 process and their CEO has resigned to become an independent buyer despite her recent bid ...
A new part of an ocean plant cell has been discovered that might revolutionize farming one day. The structure can take ...
Combining Versamune ® HPV with chemoradiation (CRT) was linked to rapid HPV16 ctDNA decline,” said Frank Bedu-Addo, PhD, President and Chief Executive Officer of PDS Biotech. “We believe that ...
The DNA-testing company’s site was slow in responding to some deletion requests, leading customers to be uncertain about the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results